Groowe Groowe / Newsroom / DRMA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

DRMA News

Dermata Therapeutics, Inc. Common Stock

Dermata Announces U.S. Trademark Registration for TOME(R)

accessnewswire.com
DRMA

Form 8-K

sec.gov
DRMA

Form 8-K

sec.gov
DRMA

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Third Quarter 2026

accessnewswire.com
DRMA

Form 8-K

sec.gov
DRMA

Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial

accessnewswire.com
DRMA

Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment

accessnewswire.com
DRMA

Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment

accessnewswire.com
DRMA

Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch

accessnewswire.com
DRMA

Form 8-K

sec.gov
DRMA DRMAW